Puma Biotechnology logo

Puma Biotechnology share price today

(PBYI)

Puma Biotechnology share price is $3.55 & ₹304.63 as on 7 Jan 2025, 2.30 'hrs' IST

$3.55

0.6

(20.34%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Puma Biotechnology share price in Dollar and Rupees. Guide to invest in Puma Biotechnology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Puma Biotechnology, along with analyst recommendations, forecasts, and comprehensive financials.

Puma Biotechnology share price movements

  • Today's Low: $3.24
    Today's High: $3.76

    Day's Volatility :13.95%

  • 52 Weeks Low: $2.23
    52 Weeks High: $7.73

    52 Weeks Volatility :71.22%

Puma Biotechnology Returns

PeriodPuma Biotechnology, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
12.6%
-8.4%
0.0%
6 Months
-2.96%
-3.8%
0.0%
1 Year
-38.8%
-0.1%
0.0%
3 Years
8.86%
2.9%
-19.8%

Puma Biotechnology Key Statistics

in dollars & INR

Previous Close
$2.95
Open
$3.21
Today's High
$3.7614
Today's Low
$3.2368
Market Capitalization
$149.7M
Today's Volume
$843.3K
52 Week High
$7.73
52 Week Low
$2.225
Revenue TTM
$243.6M
EBITDA
$44.6M
Earnings Per Share (EPS)
$0.47
PE Ratio
6.49
Profit Margin
9.54%
Quarterly Earnings Growth YOY
2.42%
Return On Equity TTM
42.32%

How to invest in Puma Biotechnology from India?

It is very easy for Indian residents to invest directly in Puma Biotechnology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Puma Biotechnology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Puma Biotechnology or PBYI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Puma Biotechnology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Puma Biotechnology shares which would translate to 0.242 fractional shares of Puma Biotechnology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Puma Biotechnology, in just a few clicks!

Returns in Puma Biotechnology for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Puma Biotechnology investment value today

Current value as on today

₹76,874

Returns

₹23,126

(-23.13%)

Returns from Puma Biotechnology Stock

₹26,349 (-26.35%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Puma Biotechnology

-39%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Puma Biotechnology on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -39% less investors are searching Puma Biotechnology in the last 30 days versus the previous period.

Global Institutional Holdings in Puma Biotechnology

  • Vanguard Group Inc

    7.41%

  • BlackRock Inc

    7.28%

  • Millennium Management LLC

    5.87%

  • Renaissance Technologies Corp

    3.61%

  • Eversept Partners, LLC

    2.63%

  • Athyrium Capital Management LP

    2.56%

Analyst Recommendation on Puma Biotechnology

Sell

    12%Buy

    37%Hold

    50%Sell

Based on 8 Wall street analysts offering stock ratings for Puma Biotechnology(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
1
Hold
3
3
3
Sell
4
4
4

Analyst Forecast on Puma Biotechnology

What analysts predicted

Upside of 22.06%

Current:

$3.55

Target:

$4.33

Insights on Puma Biotechnology

  • Price Movement

    In the last 7 days, PBYI stock has moved down by -5.8%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 43.76M → 80.54M (in $), with an average increase of 24.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -4.81M → 20.31M (in $), with an average increase of 64.3% per quarter
  • PBYI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 60.8%
  • PBYI vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 48.3%
  • Price to Sales

    ForPBYI every $1 of sales, investors are willing to pay $0.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Puma Biotechnology Financials in INR & Dollars

FY18Y/Y Change
Revenue
$251.0M
↑ 806.14%
Net Income
$-113.6M
↓ 61.1%
Net Profit Margin
-45.26%
↑ 1008.89%
FY19Y/Y Change
Revenue
$272.3M
↑ 8.49%
Net Income
$-82.7M
↓ 27.18%
Net Profit Margin
-30.38%
↑ 14.88%
FY20Y/Y Change
Revenue
$225.1M
↓ 17.33%
Net Income
$-60.0M
↓ 27.47%
Net Profit Margin
-26.65%
↑ 3.73%
FY21Y/Y Change
Revenue
$253.2M
↑ 12.48%
Net Income
$-29.1M
↓ 51.5%
Net Profit Margin
-11.49%
↑ 15.16%
FY22Y/Y Change
Revenue
$228.0M
↓ 9.95%
Net Income
$912.0K
↓ 103.13%
Net Profit Margin
0.4%
↑ 11.89%
FY23Y/Y Change
Revenue
$235.6M
↑ 3.35%
Net Income
$21.6M
↑ 2267.43%
Net Profit Margin
9.16%
↑ 8.76%
Q2 FY23Q/Q Change
Revenue
$54.6M
↑ 3.4%
Net Income
$2.1M
↑ 51.75%
Net Profit Margin
3.9%
↑ 1.25%
Q3 FY23Q/Q Change
Revenue
$56.1M
↑ 2.84%
Net Income
$5.8M
↑ 172.62%
Net Profit Margin
10.33%
↑ 6.43%
Q4 FY23Q/Q Change
Revenue
$72.2M
↑ 28.62%
Net Income
$12.3M
↑ 111.66%
Net Profit Margin
17.0%
↑ 6.67%
Q1 FY24Q/Q Change
Revenue
$43.8M
↓ 39.36%
Net Income
$-4.8M
↓ 139.25%
Net Profit Margin
-11.0%
↓ 28.0%
Q2 FY24Q/Q Change
Revenue
$47.1M
↑ 7.58%
Net Income
$-4.5M
↓ 5.94%
Net Profit Margin
-9.62%
↑ 1.38%
Q3 FY24Q/Q Change
Revenue
$80.5M
↑ 71.06%
Net Income
$20.3M
↓ 548.6%
Net Profit Margin
25.23%
↑ 34.85%
FY18Y/Y Change
Profit
$216.4M
↑ 879.19%
FY19Y/Y Change
Profit
$235.5M
↑ 8.83%
FY20Y/Y Change
Profit
$185.7M
↓ 21.15%
FY21Y/Y Change
Profit
$189.5M
↑ 2.05%
FY22Y/Y Change
Profit
$172.9M
↓ 8.76%
FY23Y/Y Change
Profit
$173.0M
↑ 0.03%
Q2 FY23Q/Q Change
Profit
$42.7M
↑ 7.97%
Q3 FY23Q/Q Change
Profit
$42.8M
↑ 0.28%
Q4 FY23Q/Q Change
Profit
$47.9M
↑ 11.73%
Q1 FY24Q/Q Change
Profit
$33.0M
↓ 30.96%
Q2 FY24Q/Q Change
Profit
$36.4M
↑ 10.25%
Q3 FY24Q/Q Change
Profit
$51.4M
↑ 41.24%
FY18Y/Y Change
Operating Cash Flow
$-24.1M
↓ 86.03%
Investing Cash Flow
$-57.6M
↑ 273.3%
Financing Cash Flow
$108.4M
↑ 44.34%
FY19Y/Y Change
Operating Cash Flow
$22.4M
↓ 192.95%
Investing Cash Flow
$5.2M
↓ 108.96%
Financing Cash Flow
$-67.1M
↓ 161.9%
FY20Y/Y Change
Operating Cash Flow
$800.0K
↓ 96.43%
Investing Cash Flow
$23.4M
↑ 353.28%
Financing Cash Flow
$100.0K
↓ 100.15%
FY21Y/Y Change
Operating Cash Flow
$20.7M
↑ 2487.5%
Investing Cash Flow
$-10.9M
↓ 146.49%
Financing Cash Flow
$-31.9M
↓ 32000.0%
FY22Y/Y Change
Operating Cash Flow
$-15.8M
↓ 176.33%
Investing Cash Flow
$7.1M
↓ 165.29%
Financing Cash Flow
$12.2M
↓ 138.24%
Q2 FY23Q/Q Change
Operating Cash Flow
$3.3M
↑ 24.71%
Investing Cash Flow
$-4.7M
↓ 73.16%
Financing Cash Flow
$0.0
-

Puma Biotechnology Technicals Summary

Sell

Neutral

Buy

Puma Biotechnology is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Puma Biotechnology Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Puma Biotechnology, Inc.
1.03%
-2.96%
-38.8%
8.86%
-66.05%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Puma Biotechnology, Inc.
6.49
6.49
0.03
0.5
0.42
0.1
NA
1.45
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Puma Biotechnology, Inc.
Sell
$149.7M
-66.05%
6.49
9.54%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Puma Biotechnology

we focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
Organization
Puma Biotechnology
Employees
185
CEO
Mr. Alan H. Auerbach
Industry
Health Technology

Management People of Puma Biotechnology

NameTitle
Mr. Alan H. Auerbach
Founder, Chairman, President, CEO & Secretary
Mr. Maximo F. Nougues
CFO & Principal Accounting Officer
Mr. Douglas Hunt B.Sc., FRAPS
Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer
Mr. Jeffrey Jerome Ludwig
Chief Commercial Officer
Mr. Mariann Ohanesian
Senior Director of Investor Relations

Important FAQs about investing in Puma Biotechnology from India :

What is Puma Biotechnology share price today?

Puma Biotechnology share price today stands at $3.55, Open: $3.21 ; Previous Close: $2.95 ; High: $3.76 ; Low: $3.24 ; 52 Week High: $7.73 ; 52 Week Low: $2.23. The stock opens at $3.21, after a previous close of $2.95. The stock reached a daily high of $3.76 and a low of $3.24, with a 52-week high of $7.73 and a 52-week low of $2.23.

Can Indians buy Puma Biotechnology shares?

Yes, Indians can invest in the Puma Biotechnology (PBYI) from India.

With INDmoney, you can buy Puma Biotechnology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Puma Biotechnology at zero transaction cost.

How can I buy Puma Biotechnology shares from India?

It is very easy to buy Puma Biotechnology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Puma Biotechnology be purchased?

Yes, you can buy fractional shares of Puma Biotechnology with INDmoney app.

What are the documents required to start investing in Puma Biotechnology stocks?

To start investing in Puma Biotechnology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Puma Biotechnology

Today’s highest price of Puma Biotechnology (PBYI) is $3.76.

Today’s lowest price of Puma Biotechnology (PBYI) is $3.24.

What is today's market capitalisation of Puma Biotechnology

Today's market capitalisation of Puma Biotechnology PBYI is 149.7M

What is the 52 Week High and Low Range of Puma Biotechnology

  • 52 Week High

    $7.73

  • 52 Week Low

    $2.23

What are the historical returns of Puma Biotechnology?

  • 1 Month Returns

    1.03%

  • 3 Months Returns

    -2.96%

  • 1 Year Returns

    -38.8%

  • 5 Years Returns

    -66.05%

Who is the Chief Executive Officer (CEO) of Puma Biotechnology

Mr. Alan H. Auerbach is the current Chief Executive Officer (CEO) of Puma Biotechnology.